Macquarie Group LTD Adma Biologics, Inc. Transaction History
Macquarie Group LTD
- $87.4 Billion
- Q1 2024
A detailed history of Macquarie Group LTD transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Macquarie Group LTD holds 248,614 shares of ADMA stock, worth $2.83 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
248,614
Previous 274,236
9.34%
Holding current value
$2.83 Million
Previous $1.24 Million
32.36%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding ADMA
# of Institutions
224Shares Held
174MCall Options Held
85.5KPut Options Held
12.8K-
Black Rock Inc. New York, NY18.2MShares$207 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.7MShares$145 Million0.0% of portfolio
-
State Street Corp Boston, MA10.6MShares$120 Million0.0% of portfolio
-
Nuveen Asset Management, LLC Chicago, IL10.5MShares$119 Million0.02% of portfolio
-
Invesco Ltd. Atlanta, GA7.8MShares$89 Million0.01% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $2.24B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...